4
Changes in Ownership
ATOSSA THERAPEUTICS, INC. Filed Acc 0001437749-21-012675
Options or other derivatives
- CFO, Gen Counsel and Secretary acquired 850,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Guse Kyle CFO, Gen Counsel and Secretary | 2021-05-14 | Grant or award · Stock Option (right to buy) | +850,000 | 850,000 | D | ||
Loading xslF345X03/rdgdoc.xml…